Wang W, Zhang Y, Zhang L, Yang C, et al. Intravenous methotrexate at a dose of 1 g/m(2) incorporated into RCHOP prevented CNS relapse in high-risk DLBCL patients: A prospective, historic controlled study. Am J Hematol 2020;95:E80-E83.
PMID: 31925808